These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 788057)

  • 41. [Lymphocyte adhesive properties in systemic lupus erythematosus].
    Isaeva LA; Levina SG; Geppe NA; Kuznetsov SL; Snesarevskaia IP
    Sov Med; 1980; (9):39-43. PubMed ID: 6158760
    [No Abstract]   [Full Text] [Related]  

  • 42. [Study of circulating immunoblasts in the peripheral blood of patients with systemic lupus erythematosus and other rheumatic diseases].
    Bulanova TD; le Go A; Alekberova ZS; Polianskaia IP
    Ter Arkh; 1980; 52(6):64-7. PubMed ID: 6967635
    [No Abstract]   [Full Text] [Related]  

  • 43. [T- and B-lymphocyte populations in systemic lupus erythematosus and glomerulonephritis].
    Shilov EM; Traianova TG; Gordovskaia NB; Speranskiĭ AI
    Urol Nefrol (Mosk); 1979; (4):13-8. PubMed ID: 314191
    [No Abstract]   [Full Text] [Related]  

  • 44. Impaired responsiveness of lymphocytes in patients with systemic lupus erythematosus.
    Suciu-Foca N; Buda JA; Thiem T; Reemtsma K
    Clin Exp Immunol; 1974 Nov; 18(3):295-301. PubMed ID: 4283364
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Pathogenesis of systemic lupus erythematosus].
    Origuchi T; Kamachi M; Eguchi K
    Nihon Rinsho; 2005 May; 63 Suppl 5():247-52. PubMed ID: 15954357
    [No Abstract]   [Full Text] [Related]  

  • 46. Costimulatory molecule CD154 in systemic lupus erythematosus and rheumatoid arthritis. Therapeutic perspectives.
    Dejica DI; Manea EM
    Roum Arch Microbiol Immunol; 2006; 65(1-2):66-74. PubMed ID: 17877113
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Receptor and non-receptor-bearing lymphocytes in untreated systemic lupus erythematosus. Variations with disease activity.
    Díaz-Jouanen E; Rivero SJ; Llorente L; Alarcón-Segovia D
    Rev Invest Clin; 1977; 29(4):265-76. PubMed ID: 304591
    [No Abstract]   [Full Text] [Related]  

  • 48. Peripheral blood lymphocyte cell surface markers during the course of systemic lupus erythematosus.
    Messner RP; Lindström FD; Williams RC
    J Clin Invest; 1973 Dec; 52(12):3046-56. PubMed ID: 4584345
    [TBL] [Abstract][Full Text] [Related]  

  • 49. B-cell proliferation and differentiation in systemic lupus erythematosus and mixed connective tissue disease.
    Kallenberg CG; van Dissel-Emiliani F; Huitema MG; Limburg PC; The TH
    J Clin Lab Immunol; 1988 Jun; 26(2):55-61. PubMed ID: 3264025
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-lymphocyte antibodies in systemic lupus erythematosus.
    Winfield JB
    Clin Rheum Dis; 1985 Dec; 11(3):523-49. PubMed ID: 3907954
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effect of levamisole (Decaris) on various immunologic parameters in patients with systemic lupus erythematosus].
    Gandzha IM; Sakharchuk VM; Lysenko GI
    Ter Arkh; 1981; 53(7):121-4. PubMed ID: 6457406
    [No Abstract]   [Full Text] [Related]  

  • 52. [Immune response of lymphocytes in SLE].
    Morimoto I; Hara M; Adachi T; Honma M
    Nihon Rinsho; 1978 Dec; 36(12):3938-45. PubMed ID: 311860
    [No Abstract]   [Full Text] [Related]  

  • 53. Immune mechanisms in systemic lupus erythematosus.
    Butler WT; Rich RR
    Perspect Nephrol Hypertens; 1976; 3():3-11. PubMed ID: 129760
    [No Abstract]   [Full Text] [Related]  

  • 54. [T- and B-systems of immunity in diseases of the connective tissue (review of the literature and the authors' data)].
    Lozovoĭ VP; Shergin SM
    Ter Arkh; 1978; 50(9):135-45. PubMed ID: 360466
    [No Abstract]   [Full Text] [Related]  

  • 55. [Immune diagnosis of collagen diseases].
    Sönnichsen N
    Z Arztl Fortbild (Jena); 1981 Jun; 75(11-12):519-21. PubMed ID: 6975540
    [No Abstract]   [Full Text] [Related]  

  • 56. [B-cell anomalies in systemic lupus erythematosus].
    Tron F; Jacquot S; Gilbert D
    Ann Med Interne (Paris); 2002 Dec; 153(8):503-12. PubMed ID: 12610424
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Autoimmunity and lymphoid malignancy in New Zealand black mice.
    Talal N
    Prog Clin Immunol; 1974; 2():101-20. PubMed ID: 4141778
    [No Abstract]   [Full Text] [Related]  

  • 58. [Lupus erythematosus: from clinical aspects to immunopathology].
    Houssiau FA
    Bull Mem Acad R Med Belg; 1999; 154(7-9):309-15; discussion 315-8. PubMed ID: 10855338
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of lymphocytotoxins of systemic lupus erythematosus (SLE) sera on T and B lymphocytes.
    Gergely P; Szegedi G; Szabó G; Fekete B; Petrányi G
    Acta Med Acad Sci Hung; 1975; 32(1):43-8. PubMed ID: 1086049
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Systemic lupus erythematosus and pregnancy.
    Bulmash JM
    Obstet Gynecol Annu; 1978; 7():153-94. PubMed ID: 149266
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.